Levoglucosenone and Its Pseudoenantiomer iso-Levoglucosenone as Scaffolds for Drug Discovery and Development
dc.contributor.author | Liu, Xin | |
dc.contributor.author | Carr, Paul D | |
dc.contributor.author | Gardiner, Michael | |
dc.contributor.author | Banwell, Martin | |
dc.contributor.author | Elbanna, Ahmed H | |
dc.contributor.author | Khalil, Zeinab G | |
dc.contributor.author | Capon, Robert J | |
dc.date.accessioned | 2022-07-13T01:40:14Z | |
dc.date.available | 2022-07-13T01:40:14Z | |
dc.date.issued | 2020 | |
dc.date.updated | 2021-08-01T08:22:26Z | |
dc.description.abstract | The bioderived platform molecule levoglucosenone (LGO, 1) and its readily prepared pseudoenantiomer (iso-LGO, 2) have each been subjected to α-iodination reactions with the product halides then being engaged in palladium-catalyzed Ullmann cross-coupling reactions with various bromonitropyridines. The corresponding α-pyridinylated derivatives such as 11 and 24, respectively, are produced as a result. Biological screening of such products reveals that certain of them display potent and selective antimicrobial and/or cytotoxic properties. In contrast, the azaindoles obtained by reductive cyclization of compounds such as 11 and 12 are essentially inactive in these respects. Preliminary mode-of-action studies are reported | en_AU |
dc.description.sponsorship | Funding from the Australian Research Council is also acknowledged | en_AU |
dc.format.mimetype | application/pdf | en_AU |
dc.identifier.issn | 2470-1343 | en_AU |
dc.identifier.uri | http://hdl.handle.net/1885/268820 | |
dc.language.iso | en_AU | en_AU |
dc.provenance | This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. | en_AU |
dc.publisher | ACS Publications | en_AU |
dc.rights | © 2020 American Chemical Society | en_AU |
dc.rights.license | ACS AuthorChoice License | en_AU |
dc.rights.uri | https://pubs.acs.org/page/policy/authorchoice_termsofuse.html | en_AU |
dc.source | ACS Omega | en_AU |
dc.title | Levoglucosenone and Its Pseudoenantiomer iso-Levoglucosenone as Scaffolds for Drug Discovery and Development | en_AU |
dc.type | Journal article | en_AU |
dcterms.accessRights | Open Access | en_AU |
local.bibliographicCitation.issue | 23 | en_AU |
local.bibliographicCitation.lastpage | 13939 | en_AU |
local.bibliographicCitation.startpage | 13926 | en_AU |
local.contributor.affiliation | Liu, Xin, College of Science, ANU | en_AU |
local.contributor.affiliation | Carr, Paul D, College of Science, ANU | en_AU |
local.contributor.affiliation | Gardiner, Michael, College of Science, ANU | en_AU |
local.contributor.affiliation | Banwell, Martin, College of Science, ANU | en_AU |
local.contributor.affiliation | Elbanna, Ahmed H, University of Queensland | en_AU |
local.contributor.affiliation | Khalil, Zeinab G, University of Queensland | en_AU |
local.contributor.affiliation | Capon, Robert J, University of Queensland | en_AU |
local.contributor.authoremail | u1072089@anu.edu.au | en_AU |
local.contributor.authoruid | Liu, Xin, u6180982 | en_AU |
local.contributor.authoruid | Carr, Paul D, u9206448 | en_AU |
local.contributor.authoruid | Gardiner, Michael, u1072089 | en_AU |
local.contributor.authoruid | Banwell, Martin, u9500594 | en_AU |
local.description.notes | Imported from ARIES | en_AU |
local.identifier.absfor | 000000 - Internal ANU use only | en_AU |
local.identifier.ariespublication | a383154xPUB13401 | en_AU |
local.identifier.citationvolume | 5 | en_AU |
local.identifier.doi | 10.1021/acsomega.0c01331 | en_AU |
local.identifier.scopusID | 2-s2.0-85087468387 | |
local.identifier.uidSubmittedBy | a383154 | en_AU |
local.publisher.url | http://pubs.acs.org/journal/acsodf | en_AU |
local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- Levoglucosenone and Its Pseudoenantiomer.pdf
- Size:
- 1.06 MB
- Format:
- Adobe Portable Document Format
- Description: